| Literature DB >> 35402272 |
Xiaolei Xu1,2,3, Cancan Gao1, Xinye Qian2, Hong'en Liu1,3, Zhan Wang1,2,3, Hu Zhou1,2,3, Ying Zhou1,3, Haijiu Wang1,3, Lizhao Hou1, Shaoshuai He1, Xiaobin Feng2, Haining Fan1,3.
Abstract
Echinococcosis is a human-animal parasitic disease caused by Echinococcosis tapeworm larvae in humans. From a global perspective, it is mainly prevalent in the mid-high latitudes of the Northern Hemisphere, and it is a widespread infectious disease. Its form, host and release areas are slightly different. In clinical practice, Echinococcus granulosus (hepatic cystic echinococcosis) is the most common. Its growth mode is swelling growth and its metastasis is more common in implanted metastasis; However, hepatic alveolar echinococcosis (HAE) is rare. It has been reported that HAE can metastasize through the blood or lymph nodes, and its invasive growth pattern is known as "carcinoma". At this time, it may be accompanied by invasion of the portal vein and inferior vena cava(IVC)or metastasis to distant organs outside the liver (such as lung, brain, lymph nodes). Most patients are in the middle or late stages, making treatment complicated. World Health Organization guidelines recommend radical resection of HAE; However, there is no consensus on lymph node dissection. To date, there have been no reports of cases of HAE accompanied by inferior vena cava-para-abdominal aortic suspected lymph node metastasis and infection. This article reports a clinical case of a complex HAE treated by the surgical method of "middle liver resection + abdominal enlarged lymph node resection + inferior vena cava repair", and histological examination was performed to illustrate the differences in microscopic pathology of alveolar echinococcosis invading the liver and lymph nodes at different magnifications. This article reviews the relevant literature on HAE and derives the latest treatment methods for HAE to provide a reference for future clinical cases of similar alveolar echinococcosis and maximize the benefits of patients.Entities:
Keywords: hepatic alveolar echinococcosis (HAE); lymph nodes; metastasis; pathological; surgery
Year: 2022 PMID: 35402272 PMCID: PMC8987535 DOI: 10.3389/fonc.2022.849047
Source DB: PubMed Journal: Front Oncol ISSN: 2234-943X Impact factor: 6.244
Laboratory and Imaging examination data on admission.
| Biochemical data | Viral markers | ||
|---|---|---|---|
| WBC, ×109/L | 4.24 | HIVAb | Negative |
| Eosinophils, ×109/L | 0.13 | HBsAg, mIU/mL | 30.6 |
| Basophils, ×109/L | 0.03 | HCVAb | Negative |
| Lymphocytes, ×109/L | 1.37 | HAVAb | Negative |
| RBC, ×1012/L | 4.15 | HDVAb | Negative |
| Haemoglobin, g/L | 115 | HEVAb | Negative |
| Platelets, ×109/L | 346 | HGVAb | Negative |
| PT-INR | 0.95 | Tumour markers | |
| PT, S | 11.4 | AFP, ng/mL | 1.65 |
| APTT, S | 30.6 | CEA, ng/mL | 0.8 |
| AlB, g/L | 42 | CA19-9, U/mL | 15.28 |
| Total protein, g/L | 72.2 | SCC, ng/mL | 0.4 |
| AST, U/L | 25 | CYFRA21-1, ng/mL | 1.62 |
| ALT, U/L | 28 | CA-125, U/mL | 23 |
| T-Bil, umol/L | 4.3 | NSE, ng/mL | 12.14 |
| ALP, U/L | 61 | ProGRP, pg/mL | 28.27 |
| γ-GGT, U/L | 22 | IgG | Positive |
| AMY, U/L | 59 | Examination of CT and MRI | |
| BUN, mmol/L | 62 | Lesion diameter, cm | 9.7 × 8.6 cm |
| Creatine, mmol/L | 45 | Lymph node diameter, cm | 2 × 2 cm |
| Natrium, mmol/L | 137.2 | Child–Pugh | A |
| Potassium, mmol/L | 4.49 | ||
| GLU, mmol/L | 4.7 | ||
| Preoperative ICG | 5.80% |
Figure 1(A) CT and MRI venous phase. The red arrow indicates that the middle hepatic vein is close to the lesion and is considered to be invaded. (B) CT and MRI delayed phase. The red arrow indicates that the right anterior branch of the portal vein is considered to be invaded. (C) CT and MRI. The red arrow indicates inferior vena cava-para-abdominal aortic swelling. Large lymph nodes are approximately 2*2 cm in diameter. The lesions are low signal, and no enhancement is seen after enhancement. Thus, lymph node metastasis of alveolar echinococcosis was considered. (D) Preoperative three-dimensional CT and imaging showed enlarged lymph nodes in the inferior vena cava-abdominal aorta. Considered secondary lymph node metastasis of alveolar echinococcosis.
The patient’s PNM stage grouping of alveolar echinococcosis.
| Stage | Category | M | |
|---|---|---|---|
| P | N | ||
| I | 1 | 0 | 0 |
| II | 2 | 0 | 0 |
| IIIa | 3 | 0 | 0 |
| IIIb | 1 | 0 | |
| 4 | 0 | 0 | |
| IV | 4 | 1 | 0 |
| any | any | 1 | |
Figure 2(A) A cheese-like or milky-yellow section of the liver specimen with a hard surface. Postoperative liver pathology observed under different magnifications of microscopy: red arrows show normal liver tissue, yellow arrows show hepatic vesicular echinococcosis lesions, and blue arrows show alveolar echinococcosis reaction zones containing inflammatory cells such as eosinophils, lymphocytes and fibroblasts. (B) An enlarged lymph node adjacent to the inferior vena cava-abdominal aorta. Postoperative lymph node pathology microscopically observed at different magnifications: yellow arrows show lymph node alveolar echinococcosis lesions, and blue arrows show the reaction zone. A wider reaction zone indicates longer invasion time. More surrounding fibrous tissue is seen, with more fibroblasts and fewer eosinophils, lymphocytes, and epithelioid cells. A narrower the reaction zone indicates shorter invasion time, with fewer corresponding fibroblasts and more eosinophils, lymphocytes, and epithelioid cells. Lymphocytes and epithelial-like cells are increased. Purple arrows show macrophages, red arrows show blood vessels, black arrows show lymph node germinal centres, orange arrows show lymphoid follicles, grey arrows show epithelioid cells, white arrows show fibrous structures of lymph nodes, and green arrows show lymphatic tissue perithelium. Postoperative pathology shows alveolar echinococcosis within the lymphoid tissue.